Jump to content
Powered by
  • BIOPRO BW
  • Healthcare industry
  • Bioeconomy

Healthcare industry

Main navigation

  • Start page
  • Healthcare industry BW

    Healthcare industry BW

    Close
    • At a glance
    • The biotechnology sector
    • Medical technology
    • The pharmaceutical industry
    • Training & university education
    • Company foundation
    • Infrastructure
    • Clusters & Networks
  • Articles

    Articles

    Close
    • Latest news
    • Selected press releases
    • Dossiers
    • Red biotechnology
    • Medical technology
    • Pharmaceutics
    • Diagnostics
    • Basic research
    • Selected publications
  • Events

    Events

    Close
  • Databases

    Databases

    Close
    • Funding
    • Healthcare industry database
    • Research institutions
  • BIOPRO services

    BIOPRO services

    Close
    • BIOPRO services and offers
    • Contacts
    • Information channels
  • de
  • en
Show menu

You are here:

  1. Home
  2. Search
Show:Results per page
  • 25Show results
  • 50Show results
  • 75Show results

Search Results

  • Press release - 07/11/2011 Hartmann AG Logo

    Third quarter: HARTMANN increases sales in all business segments

    The HARTMANN GROUP continued its growth despite the difficult conditions in the health markets. Global sales revenues increased by 5.0 percent to EUR 1,263.8 million compared to the previous year.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/third-quarter-hartmann-increases-sales-in-all-business-segments
  • Article - 10/10/2011 The photo shows five people standing in front of a board with the title "BioValley".

    Meet & Match in the BioValley – bringing together international partners

    Small life sciences companies find it particularly difficult to set aside time for making international contacts at trade fairs. The BioValley cluster located in a region bordered by Germany France and Switzerland has a team of scouts that focus on matchmaking. Dr. Mona Boy is the coordinator of the trinational matchmaking team of the BioValley cluster.

    https://www.gesundheitsindustrie-bw.de/en/article/news/meet-match-in-the-biovalley-bringing-together-international-partners
  • Article - 11/02/2013 19222_de.jpg

    Quality management: burden or opportunity?

    Companies are facing increasing demands. Globalisation and an increasingly quality-conscious market increase competition and pricing pressure. To remain globally competitive companies need a product and service quality that will satisfy the customer in the long term. Alexander Cansier managing director of OrgaConnect GmbH has specialised in the support of small and medium-sized companies in the life sciences pharmaceutical and medical technology…

    https://www.gesundheitsindustrie-bw.de/en/article/news/quality-management-burden-or-opportunity
  • Industry report 2018 - 27/09/2018 Branchenreport_Gesundheitsindustrie__Zahlen_und_Fakten_fur_Baden-Wurttemberg_Titelseite_U1.jpg

    The healthcare industry – the innovation driver of the 21st century: opportunities and challenges

    BIOPRO Baden-Württemberg’s new industry report entitled "The Healthcare Industry 2018: Facts and Figures for Baden-Württemberg" has just been published in both German and English. The topic neatly dovetails with the state’s political activities. An evaluation of the region carried out on behalf of the Baden-Württemberg government has clearly recognised the importance of the healthcare sector as a driver of innovation.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/the-healthcare-industry-the-innovation-driver-of-the-21st-century
  • Dossier - 04/07/2011 The cement-free Metha® Short Hip Stem prosthesis with Plasmapore® µ-CaP coating of the entire proximal surface supports rapid secondary fixation. µ-CaP is applied on the microporous titanium Plasmapore® surface. It has an osteoconductive effect and accelerates contact between the bone and the prosthesis stem.

    Implants of the future: bioactive, corrosion-resistant and antibacterial

    People’s life expectancy is increasing due to constantly improving medical treatment. One result of this is the greater wear of joints, which then need to be replaced with implants. Increased life expectancy means that the implants remain in the body for much longer and therefore need to be longer lasting. The revision rate of implant materials used in clinical practice is still as much as 10 per cent, particularly in the case of hip and knee…

    https://www.gesundheitsindustrie-bw.de/en/article/dossier/implants-of-the-future-bioactive-corrosion-resistant-and-antibacterial
  • Press release - 08/03/2010 The photo shows four men standing in front of a modular display system.

    Innovative microsystems – injection-moulded and printed

    Up-to-date injection moulding and printing methods can now be used to produce microtechnical components and entire functional units inexpensively and with the highest possible precision. Refined processing, coating and manufacturing techniques can make the serial production of microsystems considerably easier. Moreover, microsensors are increasingly being used as multifunctional units in the automotive, laboratory, medical and automation…

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/innovative-microsystems-injection-moulded-and-printed
  • Press release - 05/04/2011 Hartmann AG Logo

    HARTMANN continues its success

    Profitability improved despite difficult market conditions: In fiscal year 2010, HARTMANN continued its profitable growth despite unfavorable market conditions, building on its strong sales performance in the previous year. The company was confronted with increasing budget restrictions in the health systems and substantially higher raw material and logistics costs.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/hartmann-continues-its-success
  • Press release - 07/03/2011 Speaker at a speaker's desk talking to the audience.<br />

    Review: MicroMountains Innovation Forum 2011: Networking - Motor for Innovation

    The third MicroMountains Innovation Forum, held in Villingen-Schwenningen on 2nd February 2011, focused exclusively on microtechnologies. In cooperation with the local Chamber of Commerce and Industry, the MicroMountains network provided around 160 participants with insights into the application of microtechnologies in the fields of medical, measurement and automotive technologies as well as giving them the opportunity to exchange experiences.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/review-micromountains-innovation-forum-2011-networking-motor-for-innovation
  • Press release - 20/07/2018

    First closing at SHS: Medical technology investor raises over €90 million for its fifth fund

    SHS Gesellschaft für Beteiligungsmanagement has received capital commitments of over €90 million in its fifth fund's first closing. The fifth generation of SHS funds is also focused on the life sciences and medical technology sector, and thus on the growing global healthcare market with innovative and strong players, especially in Germany and Switzerland.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/first-closing-at-shs-medical-technology-investor-raises-over-90-million-for-its-fifth-fund
  • Article - 31/12/2012 18916_de.jpg

    Diagnosis of myocardial infarction: a drop of blood is all that is required

    Can myocardial infarction be diagnosed with a single drop of blood? The answer is yes: a new application of the ESEQuant Lateral Flow System developed by QIAGEN now makes this possible. The system, which is able to identify a broad range of bacterial and viral pathogens, including HIV, influenza virus and Chlamydia, was originally developed at the company’s site in Stockach. It has recently been adapted for use in the diagnosis of myocardial…

    https://www.gesundheitsindustrie-bw.de/en/article/news/diagnosis-of-myocardial-infarction-a-drop-of-blood-is-all-that-is-required
  • Article - 06/06/2011 Professor Gunter Voigt lectures and researches at HTWG Konstanz

    Knowledge transfer depends on the application of learning

    The ability of scientists from different disciplines to understand each other as well as excellent communication skills play an ever-increasing role in the transfer of knowledge from academic research to industry. Vice president of research at the Konstanz University of Applied Sciences HTWG Professor Gunter Voigt explains how academia and industry work together and also highlights the conditions that are necessary for such cooperations to lead…

    https://www.gesundheitsindustrie-bw.de/en/article/news/knowledge-transfer-depends-on-the-application-of-learning
  • Article - 17/12/2012 18957_de.jpg

    The ablation of nerves along the renal artery – a novel treatment option in the field of cardiology

    High blood pressure can normally be treated effectively with medicines. However, some patients do not respond to medicinal treatment despite several different drugs being used. Renal denervation (RDN), a novel catheter-based procedure, seems to have become a promising alternative to controlling hypertension with drugs. Professor Dr. Axel Bauer from the Tübingen University Hospital believes that this method can even be used for a much wider range…

    https://www.gesundheitsindustrie-bw.de/en/article/news/the-ablation-of-nerves-along-the-renal-artery-a-novel-treatment-option-in-the-field-of-cardiology
  • Press release - 14/07/2009 09045_de.jpg

    Amedrix GmbH - Successful cell-free products

    The cell biologist Dr. Thomas Graeve has founded Amedrix GmbH in Esslingen. In future, the company will develop and produce innovative, cell-free medical products based on animal collagen for the purpose of wound regeneration and the reconstruction of degenerated soft tissue, for example.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/amedrix-gmbh-successful-cell-free-products
  • Press release - 02/09/2011 15267_de.jpg

    German Government starts the initiative "Health - Made in Germany"

    The overall aim of the initiative is to exploit the dormant capacities that lie within the export of health care products made in Germany. In Germany, many companies are already world leaders in their fields, in part due to a policy of consistent and early promotion of health care in Germany. German technology suppliers possess decades of valuable experience in realizing health care projects both at home and abroad. Provider of products and…

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/german-government-starts-the-initiative-health-made-in-germany
  • Press release - 30/04/2009 08509_de.jpg

    Will Ulm surgeons set new standard in bypass surgery?

    A new computer-assisted navigation system, developed by an interdisciplinary team of researchers and doctors at the University of Ulm over the last three years, makes bypass surgery safer and more precise.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/will-ulm-surgeons-set-new-standard-in-bypass-surgery
  • Overview

    Pharmaceutics

    The latest articles, press releases and dossiers on pharmaceutics in Baden-Württemberg

    https://www.gesundheitsindustrie-bw.de/en/article/pharma
  • Press release - 26/11/2010 13032_de.jpg

    Singapore meets Baden-Württemberg: biotechnology and medical technology companies exchange views

    Several biotechnology and medical technology companies from Baden-Wüttemberg and Singapore interested in international cooperation met in Stuttgart on 19th November 2010. The event was organised by SRING Singapore Enterprise and BIOPRO Baden-Württemberg GmbH.

    https://www.gesundheitsindustrie-bw.de/en/article/news/singapore-meets-baden-wuerttemberg-biotechnology-and-medical-technology-companies-exchange-views
  • Article - 23/03/2017 Photo showing an urology operating theatre during urinary bladder operation. The photo shows two members of the operation team standing on the left- and right-hand side of the patient.

    CeMIT – professional innovation management for the medical device sector

    With the establishment of the Centrum für Medizintechnische Innovationen Tübingen, or CeMIT, the University Hospital of Tübingen is building a bridge between hospitals and medical device companies, which share the aim to develop new and better medical technology products and methods. Partners from small and medium-sized companies are expected to particularly benefit from the services that CeMIT provides and the guidance it can offer in finding…

    https://www.gesundheitsindustrie-bw.de/en/article/news/cemit-professional-innovation-management-for-the-medical-device-sector
  • Article - 14/07/2008

    Basis for 21st Century Medicine

    Dr. Annette Schavan the Federal Minister of Education and Research visited the famous university town of Tübingen to gain a first-hand impression of the bioregions vast potentials in the fields of biotechnology and medical technology.

    https://www.gesundheitsindustrie-bw.de/en/article/news/basis-for-21st-century-medicine
  • Article - 01/08/2008

    Many doctors, one patient file

    Patients will often see several doctors. Computer scientists at the Centre for Information and Medical Technology at the University of Heidelberg are developing a new electronic patient file to enable the smooth transfer of patient data.

    https://www.gesundheitsindustrie-bw.de/en/article/news/many-doctors-one-patient-file
  • Press release - 06/07/2012 Money

    Medicyte is receiving 4.2 Mio Euros from the European Union Seventh Framework Programm

    Medicyte, The Electrospinning Company and the Universities of Manchester and Pisa launch a European wide unique project with the aim to design a biomimetic bioartificial liver (Re-Liver). The company GABO:mi ensures professional project management. Research is receiving 4.2 Mio Euros from the European Union Seventh Framework Programme.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/medicyte-is-receiving-4-2-mio-euros-from-the-european-union-seventh-framework-programm
  • Press release - 27/10/2009 Portrait of Prof. Dr. Andreas von Deimling

    Precision Diagnosis of Brain Tumors: Antibody to Detect Enzyme Defect

    More than 100 different types of brain tumor are known in medicine. Their exact diagnosis is often difficult, because only tiny amounts of tumor tissue are usually available. Scientists of the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) and the University of Heidelberg have developed an antibody which is highly specific for the characteristic alteration of an enzyme that is typical of two dangerous types of brain tumor.…

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/precision-diagnosis-of-brain-tumors-antibody-to-detect-enzyme-defect
  • Article - 03/04/2019 team.jpg

    HKK Bionics empowers hand gripping functions

    A spin-off from the Ulm University of Applied Sciences is aiming to provide people whose hands have been paralysed due to accident or illness with a new kind of orthopaedic aid. Dominik Hepp and Tobias Knobloch are currently starting serial production of a hand orthosis prototype. The two medical engineers from Ulm, who founded HKK Bionics GmbH in 2017, plan to commence final tests in 2019.

    https://www.gesundheitsindustrie-bw.de/en/article/news/hkk-bionics-empowers-hand-gripping-functions
  • Press release - 30/09/2011 15269_de.jpg

    Blood Vessels from Your Printer

    Researchers have been working at growing tissue and organs in the laboratory for a long time. These days, tissue engineering enables us to build up artificial tissue, although science still hasn’t been successful with larger organs. Now, researchers at Fraunhofer are applying new techniques and materials to come up with artificial blood vessels in their BioRap project that will be able to supply artificial tissue and maybe even complex organs in…

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/blood-vessels-from-your-printer
  • Press release - 22/02/2010 10826_de.jpg

    AgenoLab GmbH: Improved quality of life for patients with chronic wounds

    Since its foundation three years ago, AgenoLab GmbH & Co. KG in Stuttgart has become a leading service provider in the area of life sciences and biotechnology. The company’s cell culture technology unit focuses on the preparation of cells that can largely eliminate the need for animal testing. In the area of regenerative medicine, AgenoLab GmbH concentrates on the growth of skin cells as transplants for patients suffering from burns and…

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/agenolab-gmbh-improved-quality-of-life-for-patients-with-chronic-wounds

Page 3 / 9

sb_search.block.search_result.other.pages

  • eine Seite vor
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 9
  • eine Seite zurück
  • Extend search to all portals
  • Search the Healthcare industry database
  • Search the Research institutions
Search terms
Portal
Information type
  • Type
    Event date
    From
    To
  • Type
  • Publication date
    Topics
    Topics
  • Publication date
Reset

Footer navigation

  • Healthcare industry BW
    • At a glance
    • The biotechnology sector
    • Medical technology
    • The pharmaceutical industry
    • Training & university education
    • Company foundation
    • Infrastructure
    • Clusters & Networks
  • Articles
    • Latest news
    • Selected press releases
    • Dossiers
    • Red biotechnology
    • Medical technology
    • Pharmaceutics
    • Diagnostics
    • Basic research
    • Selected publications
  • Events
  • Databases
    • Funding
    • Healthcare industry database
    • Research institutions
  • BIOPRO services
    • BIOPRO services and offers
    • Contacts
    • Information channels
  • Project pages
    • Telemedicine BW
    • MDR & IVDR
  • Portals
    • BIOPRO BW
    • Healthcare industry
    • Bioeconomy
  • To top

stay informed

Subscribe to newsletter

Social Media

  • Xing
  • Twitter
  • LinkedIn
  • Rss
  • Privacy statement
  • Legal notice
  • Sitemap
  • Contact
© 2021
Website address: https://www.gesundheitsindustrie-bw.de/en/search